The hitchhikers guide to cancer stem cell theory: Markers, pathways and therapy
暂无分享,去创建一个
[1] L. Ricci-Vitiani,et al. Targeting apoptosis pathways in cancer stem cells. , 2013, Cancer letters.
[2] M. Miyazaki,et al. Aldehyde dehydrogenase 1‐positive cells in axillary lymph node metastases after chemotherapy as a prognostic factor in patients with lymph node‐positive breast cancer , 2012, Cancer.
[3] O. Gallo,et al. Cancer stem cells hypothesis and stem cells in head and neck cancers. , 2012, Cancer treatment reviews.
[4] M. Reedijk,et al. Developmental pathways in breast cancer and breast tumor-initiating cells: therapeutic implications. , 2012, Cancer letters.
[5] G van der Pluijm,et al. The BMP2/7 heterodimer inhibits the human breast cancer stem cell subpopulation and bone metastases formation , 2012, Oncogene.
[6] Yuri Kogan,et al. Strategies for cancer stem cell elimination: insights from mathematical modeling. , 2012, Journal of theoretical biology.
[7] P. Oliver,et al. The impact of novel retinoids in combination with platinum chemotherapy on ovarian cancer stem cells. , 2012, Gynecologic oncology.
[8] Martin Götte,et al. Flow cytometry in cancer stem cell analysis and separation , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[9] J. Engh,et al. CD90 is identified as a marker for cancer stem cells in high-grade gliomas using tissue microarrays. , 2012, Neurosurgery.
[10] Lilya V. Matyunina,et al. Isolation and characterization of stem-like cells from a human ovarian cancer cell line , 2012, Molecular and Cellular Biochemistry.
[11] D. Nam,et al. Trans-Differentiation of Neural Stem Cells: A Therapeutic Mechanism Against the Radiation Induced Brain Damage , 2012, PloS one.
[12] J. Kopeček,et al. Selective inhibitory effect of HPMA copolymer-cyclopamine conjugate on prostate cancer stem cells. , 2012, Biomaterials.
[13] D. Horst,et al. The expression pattern of aldehyde dehydrogenase 1 (ALDH1) is an independent prognostic marker for low survival in colorectal tumors. , 2012, Experimental and molecular pathology.
[14] Jan Greve,et al. Automated identification of circulating tumor cells by image cytometry , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[15] J. Palazzo,et al. Dysplastic lesions in inflammatory bowel disease show increased positivity for the stem cell marker aldehyde dehydrogenase. , 2012, Human pathology.
[16] L. Ricci-Vitiani,et al. Knockdown of Ubiquitin Ligases in Glioblastoma Cancer Stem Cells Leads to Cell Death and Differentiation , 2012, Journal of biomolecular screening.
[17] D. Campana,et al. A new method for high speed, sensitive detection of minimal residual disease , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[18] S. Mocellin,et al. Prognostic Value of Putative Circulating Cancer Stem Cells in Patients Undergoing Hepatic Resection for Colorectal Liver Metastasis , 2012, Annals of Surgical Oncology.
[19] D. Louis,et al. Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cells. , 2012, Journal of the National Cancer Institute.
[20] H. Ulrich,et al. Neural differentiation of rat aorta pericyte cells , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[21] P. Rohrlich,et al. CD304 is preferentially expressed on a subset of B‐lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[22] A. Donnenberg,et al. Pericytes: A universal adult tissue stem cell? , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[23] Richard J. Jones,et al. Concise Review: Cancer Stem Cells and Minimal Residual Disease , 2012, Stem cells.
[24] H. Abken,et al. Regression of metastatic melanoma by targeting cancer stem cells , 2012, Oncotarget.
[25] Tomáš Sieger,et al. Detection and monitoring of normal and leukemic cell populations with hierarchical clustering of flow cytometry data , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[26] K. Machida,et al. Pluripotency factor-mediated expression of the leptin receptor (OB-R) links obesity to oncogenesis through tumor-initiating stem cells , 2011, Proceedings of the National Academy of Sciences.
[27] T. Stokke,et al. Prostate Cancer Cell Lines under Hypoxia Exhibit Greater Stem-Like Properties , 2011, PloS one.
[28] F. DiMeco,et al. CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays* , 2011, Molecular & Cellular Proteomics.
[29] G. Camussi,et al. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15. , 2011, Journal of the National Cancer Institute.
[30] S. Cheung,et al. Granulin-Epithelin Precursor Is an Oncofetal Protein Defining Hepatic Cancer Stem Cells , 2011, PloS one.
[31] J. Gil-Ranedo,et al. An Off-Target Nucleostemin RNAi Inhibits Growth in Human Glioblastoma-Derived Cancer Stem Cells , 2011, PloS one.
[32] Hong Peng,et al. Interactions between cancer stem cells and their niche govern metastatic colonization , 2011, Nature.
[33] N. Nguyen,et al. Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy , 2011, Journal of Translational Medicine.
[34] T. Welling,et al. c-Met is a marker of pancreatic cancer stem cells and therapeutic target. , 2011, Gastroenterology.
[35] N. Sato,et al. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity , 2011, Laboratory Investigation.
[36] Wei-ru Xu,et al. Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells , 2011, Medical oncology.
[37] D. Dinh,et al. Cord blood stem cells revert glioma stem cell EMT by down regulating transcriptional activation of Sox2 and Twist1 , 2011, Oncotarget.
[38] M. Biffoni,et al. Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy , 2011, Cell Death and Differentiation.
[39] A. Rangarajan,et al. A Monoclonal Antibody against Human Notch1 Ligand–Binding Domain Depletes Subpopulation of Putative Breast Cancer Stem–like Cells , 2011, Molecular Cancer Therapeutics.
[40] S. Shankar,et al. Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms , 2011, PloS one.
[41] Manuel Hidalgo,et al. Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy. , 2011, Cell stem cell.
[42] P. Carmeliet,et al. A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours , 2011, Nature.
[43] Pradeep S Rajendran,et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors , 2011, Nature Biotechnology.
[44] C. Beier,et al. Chemoresistance of glioblastoma cancer stem cells - much more complex than expected , 2011, Molecular Cancer.
[45] S. Fan,et al. Prediction of Posthepatectomy Recurrence of Hepatocellular Carcinoma by Circulating Cancer Stem Cells: A Prospective Study , 2011, Annals of surgery.
[46] S. Morgan. Can new optical techniques for in vivo imaging and flow cytometry of the microcirculation benefit sickle cell disease research? , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[47] Axel Mosig,et al. Circulation times of prostate cancer and hepatocellular carcinoma cells by in vivo flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[48] Hiroshi Iwasaki,et al. CD133+ Cancer Stem Cell–like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Müllerian Tumor) , 2011, Stem cells.
[49] G. Pirozzi,et al. 3‐O‐methylfunicone, from Penicillium pinophilum, is a selective inhibitor of breast cancer stem cells , 2011, Cell proliferation.
[50] R. McLendon,et al. Direct In Vivo Evidence for Tumor Propagation by Glioblastoma Cancer Stem Cells , 2011, PloS one.
[51] Mauro Biffoni,et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells , 2011, Nature.
[52] Daniel J. Hoeppner,et al. Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions , 2011, Cell Death and Disease.
[53] Huan Yang,et al. Identification of CD44+CD24+ gastric cancer stem cells , 2011, Journal of Cancer Research and Clinical Oncology.
[54] J. Petriz,et al. ABCG2 is required to control the sonic hedgehog pathway in side population cells with stem‐like properties , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[55] M. Salto‐Tellez,et al. Sequential expression of putative stem cell markers in gastric carcinogenesis , 2011, British Journal of Cancer.
[56] K. V. van Golen,et al. Breast Cancer Stem Cells Survive Periods of Farnesyl-Transferase Inhibitor-Induced Dormancy by Undergoing Autophagy , 2011, Bone marrow research.
[57] E. Dmitrovsky,et al. Hedgehog-producing cancer cells respond to and require autocrine Hedgehog activity. , 2011, Cancer research.
[58] Y. Ku,et al. Hypoxia Induces Tumor Aggressiveness and the Expansion of CD133-Positive Cells in a Hypoxia-Inducible Factor-1α-Dependent Manner in Pancreatic Cancer Cells , 2011, Pathobiology.
[59] T. Curran,et al. The Hedgehog's tale: developing strategies for targeting cancer , 2011, Nature Reviews Cancer.
[60] Stephen Gould,et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells , 2011, Proceedings of the National Academy of Sciences.
[61] J. Rich,et al. Deadly teamwork: neural cancer stem cells and the tumor microenvironment. , 2011, Cell stem cell.
[62] Mitsuru Sasako,et al. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] J. Troge,et al. Tumour evolution inferred by single-cell sequencing , 2011, Nature.
[64] H. Abken,et al. The beating heart of melanomas: a minor subset of cancer cells sustains tumor growth , 2011, Oncotarget.
[65] Mingli Liu,et al. Role of Notch and its oncogenic signaling crosstalk in breast cancer. , 2011, Biochimica et biophysica acta.
[66] J. Shen,et al. NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation , 2011, Oncogene.
[67] James R. Downing,et al. Evolution of human BCR–ABL1 lymphoblastic leukaemia-initiating cells , 2011, Nature.
[68] M. Takao,et al. Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination‐free flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[69] H. Abken,et al. Eradication of melanomas by targeted elimination of a minor subset of tumor cells , 2011, Proceedings of the National Academy of Sciences.
[70] Z. Naito,et al. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis. , 2011, World journal of gastroenterology.
[71] P. Vyas,et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. , 2011, Cancer cell.
[72] Rong Wang,et al. Glioblastoma stem-like cells give rise to tumour endothelium , 2010, Nature.
[73] Ying Lu,et al. Selection of tumorigenic melanoma cells using ALDH. , 2010, The Journal of investigative dermatology.
[74] S. Morrison,et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. , 2010, Cancer cell.
[75] W. Gianni,et al. Cancer stem cells and epithelial-mesenchymal transition: revisiting minimal residual disease. , 2010, Current cancer drug targets.
[76] Robert M Hoffman,et al. Advances in cellular, subcellular, and nanoscale imaging in vitro and in vivo , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[77] R. Bjerkvig,et al. Glioma cell populations grouped by different cell type markers drive brain tumor growth. , 2010, Cancer research.
[78] T. Schumacher,et al. Development of adoptive cell therapy for cancer: a clinical perspective. , 2010, Human gene therapy.
[79] R. McLendon,et al. Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.
[80] M. Pasca di Magliano,et al. Pancreatic Cancer and Hedgehog Pathway Signaling: New Insights , 2010, Pancreatology.
[81] Z. Agur,et al. Disruption of a Quorum Sensing mechanism triggers tumorigenesis: a simple discrete model corroborated by experiments in mammary cancer stem cells , 2010, Biology Direct.
[82] Thijs J. Hagenbeek,et al. Therapeutic antibody targeting of individual Notch receptors , 2010, Nature.
[83] S. Vandenberg,et al. A hierarchy of self-renewing tumor-initiating cell types in glioblastoma. , 2010, Cancer cell.
[84] M. Wolter,et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha. , 2010, Brain : a journal of neurology.
[85] M. Krause,et al. Cancer stem cells at the crossroads of current cancer therapy failures--radiation oncology perspective. , 2010, Seminars in cancer biology.
[86] C. Iacobuzio-Donahue,et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. , 2010, Journal of the National Cancer Institute.
[87] Xin Li,et al. Detection of circulating tumor cells in breast cancer patients utilizing multiparameter flow cytometry and assessment of the prognosis of patients in different CTCs levels , 2010, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[88] A. Flesken-Nikitin,et al. Mouse Models for Cancer Stem Cell Research , 2010, Toxicologic pathology.
[89] Justin C. Grindley,et al. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery , 2009, Nature Reviews Drug Discovery.
[90] L. Mariani,et al. Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment , 2009, Proceedings of the National Academy of Sciences.
[91] O. Er,et al. Cancer Stem Cells in Solid Tumors , 2009, Oncology Research and Treatment.
[92] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.
[93] J. D'haese,et al. Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer. , 2009, Gastroenterology.
[94] Yi-Wei Chen,et al. Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. , 2009, Biochemical and biophysical research communications.
[95] S. Rutella,et al. Cells with Characteristics of Cancer Stem/Progenitor Cells Express the CD133 Antigen in Human Endometrial Tumors , 2009, Clinical Cancer Research.
[96] David Allard,et al. Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer , 2009, Science.
[97] Hui Wang,et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. , 2009, Cancer cell.
[98] T. Wang,et al. Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44 , 2009, Stem cells.
[99] G. Daley,et al. Functional Evidence that the Self‐Renewal Gene NANOG Regulates Human Tumor Development , 2009, Stem cells.
[100] Tao Zhang,et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. , 2009, Cancer research.
[101] A. Krešo,et al. Cancer stem cells in solid tumors: an overview. , 2009, Seminars in radiation oncology.
[102] K. Camphausen,et al. Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro , 2009, Molecular Cancer Research.
[103] H. Tian,et al. Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis , 2009, Proceedings of the National Academy of Sciences.
[104] M. Korc,et al. Nestin expression correlates with nerve and retroperitoneal tissue invasion in pancreatic cancer. , 2009, Human pathology.
[105] J. Marks,et al. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells , 2009, Oncogene.
[106] G. Vereb,et al. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[107] Lei Du,et al. CD44 is of Functional Importance for Colorectal Cancer Stem Cells , 2008, Clinical Cancer Research.
[108] R. Richardson,et al. Prominin1 marks intestinal stem cells that are susceptible to neoplastic transformation , 2008, Nature.
[109] S. Morrison,et al. Efficient tumor formation by single human melanoma cells , 2008, Nature.
[110] G. Camussi,et al. Identification of a tumor‐initiating stem cell population in human renal carcinomas , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[111] J. Massagué,et al. TGFβ in Cancer , 2008, Cell.
[112] K. Chan,et al. Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations , 2008, Molecular Cancer Research.
[113] Michael Morse,et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[114] M. Clarke,et al. Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy , 2008, PloS one.
[115] Ian A. White,et al. CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors. , 2008, The Journal of clinical investigation.
[116] Curt Balch,et al. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. , 2008, Cancer research.
[117] K. Wong,et al. Direct Orthotopic Transplantation of Fresh Surgical Specimen Preserves CD133+ Tumor Cells in Clinically Relevant Mouse Models of Medulloblastoma and Glioma , 2008, Stem cells.
[118] E. Verwiel,et al. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis. , 2008, Cancer research.
[119] Susan G Hilsenbeck,et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.
[120] Hua Tian,et al. A paracrine requirement for hedgehog signalling in cancer , 2008, Nature.
[121] M. Westphal,et al. Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria , 2008, Oncogene.
[122] P. Chambon,et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signalling , 2008, Nature.
[123] S. Natsugoe,et al. CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer , 2008, British Journal of Cancer.
[124] S. Fan,et al. Identification of local and circulating cancer stem cells in human liver cancer , 2008, Hepatology.
[125] M. Biffoni,et al. Identification and expansion of the tumorigenic lung cancer stem cell population , 2008, Cell Death and Differentiation.
[126] Jian Wang,et al. CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells , 2008, International journal of cancer.
[127] Peter Canoll,et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.
[128] C. D. Salcido,et al. Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.
[129] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[130] P. Lichter,et al. Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients , 2008, Clinical Cancer Research.
[131] D. Birnbaum,et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. , 2007, Cell stem cell.
[132] M. Todaro,et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. , 2007, Cell Stem Cell.
[133] Albert D Donnenberg,et al. Tumorigenic stem and progenitor cells: implications for the therapeutic index of anti-cancer agents. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[134] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[135] M. Clarke,et al. Cancer stem cells and tumor metastasis: first steps into uncharted territory. , 2007, Cell stem cell.
[136] T. Strojnik,et al. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival. , 2007, Surgical neurology.
[137] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[138] S. Rutella,et al. Expression of CD133-1 and CD133-2 in ovarian cancer , 2007, International Journal of Gynecologic Cancer.
[139] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[140] Alexander Brawanski,et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. , 2007, Cancer research.
[141] I. Ng,et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.
[142] Jianren Gu,et al. CD133 positive hepatocellular carcinoma cells possess high capacity for tumorigenicity , 2007, International journal of cancer.
[143] H. Namba,et al. Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. , 2007, Endocrinology.
[144] J. Aster,et al. The multifaceted role of Notch in cancer. , 2007, Current opinion in genetics & development.
[145] P. Sánchez,et al. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.
[146] I. Weissman,et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma , 2007, Proceedings of the National Academy of Sciences.
[147] J. Dick,et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice , 2007, Nature.
[148] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[149] R. A. Etten,et al. Requirement for CD44 in homing and engraftment of BCR-ABL–expressing leukemic stem cells , 2006, Nature Medicine.
[150] Harikrishna Nakshatri,et al. CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis , 2006, Breast Cancer Research.
[151] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[152] M. Wicha. Cancer Stem Cells and Metastasis: Lethal Seeds , 2006, Clinical Cancer Research.
[153] Peter T Masiakos,et al. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[154] Brian Bierie,et al. Tumour microenvironment: TGFβ: the molecular Jekyll and Hyde of cancer , 2006, Nature Reviews Cancer.
[155] G. Dontu,et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.
[156] S. Morrison,et al. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells , 2006, Nature.
[157] Linheng Li,et al. Normal stem cells and cancer stem cells: the niche matters. , 2006, Cancer research.
[158] R. Hill. Identifying cancer stem cells in solid tumors: case not proven. , 2006, Cancer research.
[159] N. Maitland,et al. Prospective identification of tumorigenic prostate cancer stem cells. , 2005, Cancer research.
[160] B. Petersen,et al. AUTOIMMUNE PANCREATITIS: DIAGNOSIS USING HISTOLOGY, IMAGING, SEROLOGY, OTHER ORGAN INVOLVEMENT AND RESPONSE TO STEROIDS , 2005 .
[161] D. Elder,et al. A tumorigenic subpopulation with stem cell properties in melanomas. , 2005, Cancer research.
[162] E. Fredlund,et al. Hypoxia-induced dedifferentiation of tumor cells--a mechanism behind heterogeneity and aggressiveness of solid tumors. , 2005, Seminars in cell & developmental biology.
[163] R. Schneider-Broussard,et al. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. , 2005, Cancer research.
[164] Danila Coradini,et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. , 2005, Cancer research.
[165] T. Jacks,et al. Identification of Bronchioalveolar Stem Cells in Normal Lung and Lung Cancer , 2005, Cell.
[166] H. Clevers,et al. Wnt signalling in stem cells and cancer , 2005, Nature.
[167] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[168] F. Gage,et al. Cell fusion-independent differentiation of neural stem cells to the endothelial lineage , 2004, Nature.
[169] J. Dick,et al. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity , 2004, Nature Immunology.
[170] I. Weissman,et al. Therapeutic implications of cancer stem cells. , 2004, Current opinion in genetics & development.
[171] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[172] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[173] J. Dick,et al. High level engraftment of NOD/SCID mice by primitive normal and leukemic hematopoietic cells from patients with chronic myeloid leukemia in chronic phase. , 1998, Blood.
[174] J. Dick,et al. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell , 1997, Nature Medicine.
[175] J. Dick,et al. Normal and leukemic SCID-repopulating cells (SRC) coexist in the bone marrow and peripheral blood from CML patients in chronic phase, whereas leukemic SRC are detected in blast crisis. , 1996, Blood.
[176] M. Caligiuri,et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice , 1994, Nature.
[177] T. Lapidot,et al. Leukemia in Chronic Phase Leukemic Hematopoietic Cells From Patients With Chronic Myeloid High Level Engraftment of NOD/SCID Mice by Primitive Normal and , 2014 .
[178] R. Arceci,et al. Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival , 2012 .
[179] J. Burns,et al. Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the Mesenkillers. , 2011, American journal of cancer research.
[180] J. Vieweg,et al. E-cadherin plasticity in prostate cancer stem cell invasion. , 2011, American journal of cancer research.
[181] Jian Tu,et al. A higher number of circulating tumor cells (CTC) in peripheral blood indicates poor prognosis in prostate cancer patients--a meta-analysis. , 2011, Asian Pacific journal of cancer prevention : APJCP.
[182] Harikrishna Nakshatri,et al. Breast cancer stem cells and intrinsic subtypes: controversies rage on. , 2009, Current stem cell research & therapy.
[183] Myriam Alcalay,et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells , 2009, Nature.
[184] Tannishtha Reya,et al. Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia , 2009, Nature.
[185] J. Massagué,et al. Beyond tumorigenesis: cancer stem cells in metastasis , 2007, Cell Research.
[186] I. Bayazitov,et al. A perivascular niche for brain tumor stem cells. , 2007, Cancer cell.